Rankings
▼
Calendar
ARQT Q1 2018 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-2.83
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$21,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$2M
Cash & Equivalents
-$3M
← FY 2018
All Quarters
Q2 2018 →